Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol. 2001, 2: 533-543. 10.1016/S1470-2045(01)00486-7.
Article
CAS
PubMed
Google Scholar
Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985, 56: 918-928. 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E.
Article
CAS
PubMed
Google Scholar
Levine AJ: p53, the cellular gatekeeper for growth and division. Cell. 1997, 88: 323-331. 10.1016/S0092-8674(00)81871-1.
Article
CAS
PubMed
Google Scholar
Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 1994, 54: 3391-3395.
CAS
PubMed
Google Scholar
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell. 1993, 75: 817-825. 10.1016/0092-8674(93)90500-P.
Article
CAS
PubMed
Google Scholar
Chen J, Marechal V, Levine AJ: Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol. 1993, 13: 4107-4114.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kubbutat MH, Ludwig RL, Ashcroft M, Vousden KH: Regulation of Mdm2-directed degradation by the C terminus of p53. Mol Cell Biol. 1998, 18: 5690-5698.
Article
PubMed Central
CAS
PubMed
Google Scholar
Moll UM, Petrenko O: The MDM2-p53 interaction. Mol Cancer Res. 2003, 1: 1001-1008.
CAS
PubMed
Google Scholar
Naka T, Toyota N, Kaneko T, Kaibara N: Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res. 1998, 18: 555-564.
CAS
PubMed
Google Scholar
Qin LF, Ng IO: Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis. Hum Pathol. 2001, 32: 778-784. 10.1053/hupa.2001.27105.
Article
CAS
PubMed
Google Scholar
Schoniger-Hekele M, Hanel S, Wrba F, Muller C: Hepatocellular carcinoma--survival and clinical characteristics in relation to various histologic molecular markers in Western patients. Liver Int. 2005, 25: 62-69. 10.1111/j.1478-3231.2004.0997.x.
Article
PubMed
Google Scholar
Sung CO, Yoo BC, Koh KC, Cho JW, Park CK: Prognostic significance of p53 overexpression after hepatic resection of hepatocellular carcinoma. Korean J Gastroenterol. 2005, 45: 425-430.
PubMed
Google Scholar
Terris B, Laurent-Puig P, Belghitti J, Degott C, Henin D, Flejou JF: Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in France. Int J Cancer. 1997, 74: 614-619. 10.1002/(SICI)1097-0215(19971219)74:6<614::AID-IJC10>3.0.CO;2-5.
Article
CAS
PubMed
Google Scholar
Tseng PL, Tai MH, Huang CC, Wang CC, Lin JW, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM: Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients. J Surg Oncol. 2008, 98 (5): 349-57. 10.1002/jso.21109.
Article
PubMed
Google Scholar
Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM: P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Liver Int. 2007, 27: 772-781. 10.1111/j.1478-3231.2007.01499.x.
Article
PubMed
Google Scholar
Bahnassi AA, Zekri AR, El-Houssini S, Mokhtar NM, Abdel-Aziz AO, Sherif GM, El-Mishad AM, Khaled HM: Hepatitis C virus-NS3P in relation to p53, p21waf, mdm2, p21-ras and c-erbB2 in hepatocarcinogenesis. J Gastroenterol Hepatol. 2005, 20: 1731-1740. 10.1111/j.1440-1746.2005.04002.x.
Article
CAS
PubMed
Google Scholar
Miao J, Chen GG, Chun SY, Lai PP: Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression. Cancer Lett. 2006, 236: 115-124. 10.1016/j.canlet.2005.05.014.
Article
CAS
PubMed
Google Scholar
Yun JP, Chew EC, Liew CT, Chan JY, Jin ML, Ding MX, Fai YH, Li HK, Liang XM, Wu QL: Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix. J Cell Biochem. 2003, 90: 1140-1148. 10.1002/jcb.10706.
Article
CAS
PubMed
Google Scholar
Yun JP, Zhang MF, Hou JH, Tian QH, Fu J, Liang XM, Wu QL, Rong TH: Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases. BMC Cancer. 2007, 7: 38-10.1186/1471-2407-7-38.
Article
PubMed Central
PubMed
Google Scholar
Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP: Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer. 2007, 43: 979-992. 10.1016/j.ejca.2007.01.004.
Article
CAS
PubMed
Google Scholar
el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994, 54: 1169-1174.
CAS
PubMed
Google Scholar
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature. 1993, 366: 701-704. 10.1038/366701a0.
Article
CAS
PubMed
Google Scholar
Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 1994, 76: 1013-1023. 10.1016/0092-8674(94)90379-4.
Article
CAS
PubMed
Google Scholar
Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Bertacca G, Chella A, Merlo G, Angeletti CA, Dalla Palma P: p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene. 1996, 12: 1319-1324.
CAS
PubMed
Google Scholar
Tron VA, Tang L, Yong WP, Trotter MJ: Differentiation-associated overexpression of the cyclin-dependent kinase inhibitor p21waf-1 in human cutaneous squamous cell carcinoma. Am J Pathol. 1996, 149: 1139-1146.
PubMed Central
CAS
PubMed
Google Scholar
el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR: Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 1995, 55: 2910-2919.
CAS
PubMed
Google Scholar
Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH, Felix J, Jones LA, Hall FL, Press MF: WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol. 1997, 150: 167-175.
PubMed Central
CAS
PubMed
Google Scholar
Qin LF, Ng IO, Fan ST, Ng M: p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int J Cancer. 1998, 79: 424-428. 10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4.
Article
CAS
PubMed
Google Scholar
Albrecht JH, Meyer AH, Hu MY: Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. Hepatology. 1997, 25: 557-563. 10.1002/hep.510250311.
Article
CAS
PubMed
Google Scholar
Wagayama H, Shiraki K, Yamanaka T, Sugimoto K, Ito T, Fujikawa K, Takase K, Nakano T: p21WAF1/CTP1 expression and hepatitis virus type. Dig Dis Sci. 2001, 46: 2074-2079. 10.1023/A:1011977923941.
Article
CAS
PubMed
Google Scholar
Wagayama H, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Yamanaka T, Takase K, Nakano T: High expression of p21WAF1/CIP1 is correlated with human hepatocellular carcinoma in patients with hepatitis C virus-associated chronic liver diseases. Hum Pathol. 2002, 33: 429-434. 10.1053/hupa.2002.124724.
Article
CAS
PubMed
Google Scholar
Hu TH, Wang CC, Huang CC, Chen CL, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS: Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection. Oncol Rep. 2007, 18: 1417-1426.
PubMed
Google Scholar
Bandoh N, Hayashi T, Takahara M, Kishibe K, Ogino T, Katayama A, Imada M, Nonaka S, Harabuchi Y: Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma. Acta Otolaryngol. 2005, 125: 779-785. 10.1080/00016480410023056.
Article
CAS
PubMed
Google Scholar
Bahnassy AA, Zekri AR, Abdallah S, El-Shehaby AM, Sherif GM: Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Pathol Int. 2005, 55: 53-62. 10.1111/j.1440-1827.2005.01804.x.
Article
CAS
PubMed
Google Scholar
Turbin DA, Cheang MC, Bajdik CD, Gelmon KA, Yorida E, De Luca A, Nielsen TO, Huntsman DG, Gilks CB: MDM2 protein expression is a negative prognostic marker in breast carcinoma. Mod Pathol. 2006, 19: 69-74. 10.1038/modpathol.3800484.
Article
CAS
PubMed
Google Scholar
Doganavsargil B, Simsir A, Boyacioglu H, Cal C, Hekimgil M: A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma. BJU Int. 2006, 97: 644-648. 10.1111/j.1464-410X.2006.06054.x.
Article
CAS
PubMed
Google Scholar
Drebber U, Baldus SE, Nolden B, Grass G, Bollschweiler E, Dienes HP, Holscher AH, Monig SP: The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. Oncol Rep. 2008, 19: 1477-1483.
PubMed
Google Scholar
Seo YH, Joo YE, Choi SK, Rew JS, Park CS, Kim SJ: Prognostic significance of p21 and p53 expression in gastric cancer. Korean J Intern Med. 2003, 18: 98-103.
Article
PubMed Central
CAS
PubMed
Google Scholar
Schmider A, Gee C, Friedmann W, Lukas JJ, Press MF, Lichtenegger W, Reles A: p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma. Gynecol Oncol. 2000, 77: 237-242. 10.1006/gyno.2000.5748.
Article
CAS
PubMed
Google Scholar
Dogan E, Saygili U, Tuna B, Gol M, Gurel D, Acar B, Koyuncuoglu M: p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis. Gynecol Oncol. 2005, 97: 46-52. 10.1016/j.ygyno.2004.12.053.
Article
CAS
PubMed
Google Scholar